Breaking News Instant updates and real-time market news.

PTON

Peloton

$32.10

-0.55 (-1.68%)

07:16
12/12/19
12/12
07:16
12/12/19
07:16

Peloton price target raised to $40 from $30 at UBS

UBS analyst Eric Sheridan raised his price target on Peloton to $40 and kept his Buy rating following his recent meetings with the company management this week. The analyst contends that Peloton's guidance and Street consensus may prove conservative in the holiday quarter amid increasing consumer adoption and brand awareness relative to the "large global addressable opportunity", growth in hardware offerings and subscribers with improving conversion thanks to the new Home Trial initiative, and the momentum in the company's international markets.

PTON Peloton
$32.10

-0.55 (-1.68%)

12/05/19
STFL
12/05/19
NO CHANGE
Target $37
STFL
Buy
Peloton expands reach with digital-only price cut, app releases, says Stifel
Stifel analyst Scott Devitt noted that yesterday Peloton (PTON) lowered the price of its digital-only offering to $12.99 a month, from $19.49, while maintaining the company's core membership price at $39 a month. Peloton also launched its Peloton Digital offering on two additional platforms with new apps on Apple Watch (AAPL) and Fire TV (AMZN), noted Devitt. The analyst, who sees both moves expanding the reach of the company's digital-only offering while improving accessibility, keeps a Buy rating and $37 price target on Peloton shares.
12/09/19
BARD
12/09/19
NO CHANGE
Target $35
BARD
Outperform
Peloton remains positoned for strong holiday season, says Baird
Baird analyst Jonathan Komp met with Peloton management and came away incrementally more positive regarding its positioning for a strong holiday season. The company said they are disappointed with the interpretation of its "The Gift" commercial but said the controversy is helping drive brand awareness and its loyal members are showing support. The analyst expects the company to sustain near-term momentum and to demonstrate a quicker multi-year oath to profitability. Komp reiterated his Outperform rating and $35 price target on Peloton shares.
12/10/19
KEYB
12/10/19
NO CHANGE
Target $45
KEYB
Overweight
Peloton TV ad 'actually increases' brand awareness, says KeyBanc
KeyBanc analyst Edward Yruma says he believes Peloton has one of the strongest growth trajectories in his coverage. Yruma tells investors that his ongoing store checks point to continued momentum around home trials, and he believes that the program is providing sales with an important tool to close transactions. Additionally, Yruma says his firm's Key First Look Data point to a strong start to holiday and thinks that the recent "brouhaha" about a television advertisement actually increases brand awareness. Yruma keeps an Overweight rating and $45 price target on the shares.
12/10/19
OPCO
12/10/19
NO CHANGE
Target $38
OPCO
Outperform
Peloton price target raised to $38 from $29 at Oppenheimer
Oppenheimer analyst Jason Helfstein raised his price target for Peloton to $38 from $29, in line with peer valuations on gross profit, even though Peloton is anticipated to grow faster than peers. Helfstein tells investors in a research note that his bullishness is further supported by strong search trends, website traffic and improving customer satisfaction. Peloton also announced a 33% price reduction in its Digital Membership, which Helfstein says should be a positive catalyst to increase "top of the funnel" growth as 10% of Digital Members convert to Connected Fitness Subscribers.

TODAY'S FREE FLY STORIES

TXN

Texas Instruments

$133.66

2.81 (2.15%)

, KMI

Kinder Morgan

$21.05

0.12 (0.57%)

14:22
01/22/20
01/22
14:22
01/22/20
14:22
Earnings
Notable companies reporting after market close »

Notable companies…

TXN

Texas Instruments

$133.66

2.81 (2.15%)

KMI

Kinder Morgan

$21.05

0.12 (0.57%)

CTXS

Citrix

$119.46

1.67 (1.42%)

TER

Teradyne

$73.17

1.64 (2.29%)

PTC

PTC

$79.86

0.93 (1.18%)

STLD

Steel Dynamics

$32.05

0.14 (0.44%)

SLM

Sallie Mae

$9.15

0.31 (3.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 29

    Jan

  • 12

    Feb

  • 26

    Feb

XOM

Exxon Mobil

$67.01

-0.58 (-0.86%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Periodicals
Exxon Mobil set to kick off U.K., Germany asset sales, Bloomberg says »

Exxon Mobil intends to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

CHEOY

Cochlear

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Downgrade
Cochlear rating change  »

Cochlear downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
01/22/20
01/22
14:17
01/22/20
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
01/22/20
01/22
14:16
01/22/20
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPG

Simon Property

$146.15

-2.96 (-1.99%)

14:15
01/22/20
01/22
14:15
01/22/20
14:15
Options
Simon Property put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

, PKX

Posco

$51.39

-0.15 (-0.29%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
On The Fly
FuelCell plunges on bigger than expected loss, revenue miss »

Shares of FuelCell (FCEL)…

FCEL

FuelCell

$2.15

-0.725 (-25.26%)

PKX

Posco

$51.39

-0.15 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 31

    Jan

NK

NantKwest

$5.94

-0.32 (-5.11%)

14:14
01/22/20
01/22
14:14
01/22/20
14:14
Hot Stocks
Breaking Hot Stocks news story on NantKwest 

NantKwest trading resumes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NK

NantKwest

$5.90

-0.36 (-5.75%)

14:09
01/22/20
01/22
14:09
01/22/20
14:09
Hot Stocks
Breaking Hot Stocks news story on NantKwest »

NantKwest trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRP

Neurotrope

$2.73

1.3 (90.91%)

14:08
01/22/20
01/22
14:08
01/22/20
14:08
Syndicate
Neurotrope announces $18M registered direct offering »

Neurotrope announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$222.17

0.69 (0.31%)

, TWTR

Twitter

$34.34

0.25 (0.73%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
On The Fly
#SocialStocks: No ads in WhatsApp, No edit button for Twitter »

Welcome to…

FB

Facebook

$222.17

0.69 (0.31%)

TWTR

Twitter

$34.34

0.25 (0.73%)

SNAP

Snap

$19.25

0.24 (1.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 23

    Jan

  • 27

    Jan

  • 29

    Jan

  • 04

    Feb

  • 06

    Feb

MPLX

MPLX

$25.13

-0.54 (-2.10%)

14:05
01/22/20
01/22
14:05
01/22/20
14:05
Options
MPLX call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

BA

Boeing

$310.94

-2.37 (-0.76%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Periodicals
Boeing CEO says 737 MAX return delayed due to simulator training, CNBC reports »

Boeing CEO Dave Calhoun…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

CNCE

Concert Pharmaceuticals

$10.86

1.04 (10.59%)

14:04
01/22/20
01/22
14:04
01/22/20
14:04
Recommendations
Concert Pharmaceuticals analyst commentary  »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$311.75

-1.56 (-0.50%)

13:58
01/22/20
01/22
13:58
01/22/20
13:58
Periodicals
Boeing aims to resume 737 MAX production before return to service, CNBC says »

Dave Calhoun, the new CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

TEVA

Teva

$10.53

0.505 (5.04%)

13:55
01/22/20
01/22
13:55
01/22/20
13:55
Conference/Events
The Food and Drug Law Institute holds a webinar »

The FDLI summarizes the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 10

    Feb

  • 12

    Feb

  • 09

    Mar

CNCE

Concert Pharmaceuticals

$10.37

0.55 (5.60%)

13:53
01/22/20
01/22
13:53
01/22/20
13:53
Recommendations
Concert Pharmaceuticals analyst commentary  »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAF

GrafTech

$13.00

0.61 (4.92%)

13:45
01/22/20
01/22
13:45
01/22/20
13:45
Options
GrafTech call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

MSFT

Microsoft

$166.62

0.14 (0.08%)

13:38
01/22/20
01/22
13:38
01/22/20
13:38
Hot Stocks
Microsoft: Misconfiguration investigation found no malicious use of database »

Microsoft said in a blog…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 25

    Feb

13:35
01/22/20
01/22
13:35
01/22/20
13:35
General news
Treasury Action: there's been no real inspiration in the markets today »

Treasury Action:…

MDP

Meredith

$30.49

-0.1 (-0.33%)

13:34
01/22/20
01/22
13:34
01/22/20
13:34
Hot Stocks
Meredith to partner with Ayesha Curry to launch new quarterly brand »

Meredith Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Apr

BA

Boeing

$304.40

-8.91 (-2.84%)

13:31
01/22/20
01/22
13:31
01/22/20
13:31
Periodicals
Boeing CEO says 737 MAX output may restart in 'a few months,' Bloomberg reports »

Bloomberg cites comments…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

VFF

Village Farms

$5.84

0.01 (0.17%)

13:30
01/22/20
01/22
13:30
01/22/20
13:30
Options
Buyer crosses wide spread for Village Farm upside calls »

Buyer crosses wide spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NYT

New York Times

$33.66

-0.02 (-0.06%)

13:27
01/22/20
01/22
13:27
01/22/20
13:27
Periodicals
New York Times seen as potential suitor for 'Serial' podcast maker, WSJ says »

Serial Productions, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

JBLU

JetBlue

$19.82

0.725 (3.80%)

13:25
01/22/20
01/22
13:25
01/22/20
13:25
Options
JetBlue call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.